2.4 C
New York
Saturday 27 November 2021

Buy now


HomePoliticsIndiaPoonawalla receiving threats or playing corporate game?

Poonawalla receiving threats or playing corporate game?

Adar Poonawalla complains of being vilified and threatened and hints at starting a new production unit in the UK amid stiff competition in the vaccine market


Following the European Union’s pressure on AstraZeneca whose Covid-19 vaccine Covishield is manufactured by India-based Serum Institute of India (SII), Adar Poonawalla, head of the manufacturing facility, has complained of threats from politicians and “powerful men” demanding quick delivery of the Covid-19 vaccine that his firm has been producing.

In an interview to a London newspaper, Poonawalla complained of being “vilified and blamed”, and hinted at starting a new vaccine production unit in the United Kingdom.

“‘Threats’ is an understatement” to describe what he faced from people demanding “instant supplies” of the vaccine, Poonawalla said in an interview. He said he had received calls from “some of the most powerful men in India”, including “chief ministers…, heads of business conglomerates and others”.

“The level of expectation and aggression is really unprecedented. It’s overwhelming. Everyone feels they should get the vaccine. They can’t understand why anyone else should get it before them,” Poonawalla said in the interview.

“They are saying if you ’t give us the vaccine it’s not going to be good… It’s not foul language. It’s the tone. It’s the implication of what they might do if I don’t comply. It’s taking control. It’s coming over and basically surrounding the place and not letting us do anything unless we give in to their demands,” Poonawalla said.

Not so long ago, Adar Poonawalla was complaining of US restrictions on exports of constituents of his vaccine. He also said his capacity for high production was strained.

In the meantime, scientists showered high praise on the wholly Indian product Covaxin, developed by Bharat Biotech, the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), which they said worked well even against the double mutant variant of the coronavirus.

Meanwhile, the European Commission launched legal proceedings against the Anglo-Swedish drugmaker AstraZeneca, alleging that it did not respect its contract or have a “reliable” plan to ensure timely deliveries of vaccine doses. 

Now, Poonawalla has been in London with his family for the last few days. Media reports said he “flew to London to join his wife and two children hours before Britain banned travellers from India eight days ago”.

Poonawalla said that he was “staying here (in the UK) an extended time because I ’t want to go back to that situation” whereas Europe is the hotbed of the ‘vaccine war’ at the moment.

“Everything falls on my shoulders but I can’t do it alone… I ’t want to be in a situation where you are just trying to do your job, and just because you can’t supply the needs of X, Y or Z you really don’t want to guess what they are going to do,” Poonawalla said in the interview.

Late on 1 May, the SII CEO posted on Twitter: “Had an excellent meeting with all our partners & stakeholders in the UK Meanwhile, pleased to state that COVISHIELD’s production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days.”

Asked who must carry the blame for the situation India finds itself in, Poonawalla said: “If I give you the answer, or any answer, my head would be chopped off… I can’t comment on the elections or Kumbh Mela. It’s too sensitive… I ’t think even God could have forecast it was going to get this bad.”

Cyrus Poonawalla, the father of the SII CEO and chairman of the Poonawalla Group, said, “Adar goes to various places as and when required due to work, and this time has taken his family with him.”

Poonawalla faces formidable competition

SII is producing the Covid-19 vaccine Covishield developed by AstraZeneca and Oxford University. The SII has supplied 90% of the vaccine doses that have been given to Indian nationals so far. In the last few weeks, however, vaccines have been in short supply in the country, amidst a swelling demand, while scientists are vouching for the efficacy of the wholly India-made Covaxin. But the competition would become stiffer when India begins getting vaccines now available in the US and European countries.

A pharmaceutical industry watcher told Sirf News he believes Poonawalla is making a “hoax call” either to draw attention to “his value, wriggle out of the situation of scarcity or to influence the government”.

“His value will reduce further when other vaccines that are being administered in the US, Russia and other European countries arrive in India,” the source said. Americans are largely receiving doses of the vaccine developed by Pfizer-BioNTech, followed by that made by Moderna. Johnson & Johnson’s Janssen also is in the market. Russia’s product is Sputnik.

As of January 2021, authorised vaccines of the adenovirus vector type are the Oxford–AstraZeneca’s Covishield, the Sputnik V, Convidecia and the Johnson & Johnson’s COVID-19 vaccine.

As of January 2021, authorised vaccines of the inactivated type are the Chinese CoronaVac, BBIBP-CorV and WIBP-CorV, the Indian and the Russian CoviVac. Vaccines in clinical trials include Valneva.

As of April 2021, the two authorised subunit vaccines are the peptide vaccine EpiVacCorona and RBD-Dimer.

Vaccines with pending authorisations include the Novavax, SOBERANA 02 (a conjugate vaccine) and the Sanofi–GSK vaccine. The V451 vaccine was previously in clinical trials, which were terminated because it was found that the vaccine may potentially cause incorrect results for subsequent HIV testing.

Sirf News needs to recruit journalists in large numbers to increase the volume of its reports and articles to at least 100 a day, which will make us mainstream, which is necessary to challenge the anti-India discourse by established media houses. Besides there are monthly liabilities like the subscription fees of news agencies, the cost of a dedicated server, office maintenance, marketing expenses, etc. Donation is our only source of income. Please serve the cause of the nation by donating generously.

Support pro-India journalism by donating via UPI to surajit.dasgupta@icici

Speedy Justice to Consumers! ⚖

With easy & simple e-filing of complaints, the e-Daakhil portal is providing hassle-free grievance redressal to consumers by protecting their rights across the country.

This is a major step towards empowering consumers.🛍


कांग्रेस के अजीज कुरैशी कहते हैं AMU मे जिन्ना की बड़ी फोटो लगे।अखिलेश यादव Jinnah को नेहरू, गांधी के बराबर का स्वतंत्रता सेनानी मानते हैं।
क्या यह साफ-साफ तुष्टीकरण की राजनीति नहीं है?
@Shehzad_Ind https://twitter.com/indiatvnews/status/1464561419702071296

India TV@indiatvnews

यूपी की लड़ाई धर्म पर कैसे आई ?

यूपी में दंगाई 'जिन्ना' के अनुयायी ?

'जिन्ना' चलेगा या गन्ना ?

#Muqabla LIVE with @Surbhi_R_Sharma

Guests- @Shehzad_Ind , @VijayVst0502 , @ameeque_Jamei , #MHKhan , @shadab_chouhan1

#UPPolitics #UPElection https://twitter.com/i/broadcasts/1RDGlgBzkldKL


PM @narendramodi congratulates IIGF’s efforts towards defining roadmap on internet governance

Future of Internet must be shaped by open societies sharing same set of democratic values and citizen right : @Rajeev_GoI


Centre's bid to curb crypto … Bill to regulate on the table.

Why does crypto need curbs? Should India just ban crypto? Find out from the best experts.

@Subhashgarg1960 & @DrArunaSharma6 join Rahul Shivshankar on CONVERSE INDIA @ 8:30pm.


@Shehzad_Ind ने कहा अखिलेश, राजभर और ओवैसी ये बिरयानी भाई जान का एजेंडा एक ही है हिन्दूत्व के नाम पर डराओ, भडकाओ और वोट कमाओ


Read further:

This site uses Akismet to reduce spam. Learn how your comment data is processed.

- Advertisment -